BME Capstone @ the Design Garden

  • Design Garden
  • Design Innovation Process
    • Global Health Capstone
    • STAT Credentialing Program
    • Voice of the Customer
    • User Needs and Design Inputs
    • Intellectual Property
    • Ideation
    • Prototyping Resources
    • Regulatory Affairs
    • Market Assessment
  • Spring 2025 Capstone Expo Showcase
    • F24 Expo Project Showcase
    • S24 Expo Project Showcase
  • Sponsor a Project
  • Contact Us

F21 Project: JVPro

Connect our team on LinkedIN! 


Rodriguez, Samantha; Venkata, Akshaya

 

JVPros

 

Noninvasive Jugular Venous Pressure Waveform Detection Device for Congestive Heart Failure Patients

A noninvasive, wearable device for a reliable and accurate means of measuring jugular venous pressure in heart failure patients.

Project Description: 

In the United States, there are approximately 5 million patients with congestive heart failure (CHF). Of these 5 million patients, roughly 1 million require a right heart catheterization each year, at a cost of $5,000 each. The right heart catheterization, while expensive, is essential in assessing a patient’s right atrial pressure and its waveform to help treat fluid build up. The alternative to this procedure is an assessment of Jugular Venous Pressure (JVP) by visual inspection which leads to inconsistencies resulting in ineffective treatment. Our device – the JVPro – aims to provide cardiologists with a more accurate JVP waveform. In order to meet this requirement, this device incorporates two critical sensors: electrocardiography and photoplethysmography. Typically, patients with CHF are already wearing these sensors in the hospital and this device will incorporate them by strapping onto the patient’s chest without inhibiting movement.The JVPro will collect the waveforms from each of the sensors separately and correlate the time difference between peaks in order to compute Pulse Arrival Time (PAT). Using an algorithm, PAT will then be converted to the JVP waveform, which will enable doctors to determine the mean JVP and administer the appropriate treatment. Further steps for this device include an output of the mean JVP, which will further expedite IV drug prescription. Before going to market, this device must undergo clinical testing and be compared to the gold standard Right Heart Catheter.

Omid, Behbahani-Nejad, MD, MS

Resident Physician, PGY-2, Internal Medicine, Medical Innovation Distinction Track

Emory University School of Medicine

 

Submit a Project Proposal

Design Garden Resources

Previous Projects
Sponsor a Project
Design Resources
Global Health Capstone
STAT Credentialing Program

BME Resources

Capstone Design
Coulter Department of Biomedical Engineering

313 Ferst Drive 
Atlanta, GA 30332 
404.385.0124

Contact Us

Capstone Instructional Team
Schedule a Meeting
WordPress Log in
  • Follow
  • Follow

Success!

Subscribe